Jochen Maas
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
-
- Chemical Reactions and Isotopes 2
- Co-authors
- Douglas Lazarus (1 shared paper)J I Johnson (1 shared paper)Julian Adams (1 shared paper)Vito J. Palombella (1 shared paper)Christine Pien (1 shared paper)Edward A. Sausville (1 shared paper)Antonia T. Destree (1 shared paper)Peter J. Elliott (1 shared paper)
- Journals
- Regulatory Toxicology and Pharmacology (2 papers)Drug Metabolism Reviews (1 paper)Biochimica et Biophysica Acta (BBA) - General Subjects (1 paper)Journal of drug targeting (1 paper)Handbook of experimental pharmacology (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Jochen Maas
20 papers receiving 1.9k citations
Jochen Maas's Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 306
- Oncology 510
- Molecular Biology 1.1k
- Pharmacology 123
- Hepatology 86
Countries citing papers authored by Jochen Maas
This map shows the geographic impact of Jochen Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Maas more than expected).
Fields of papers citing papers by Jochen Maas
This network shows the impact of papers produced by Jochen Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Maas. The network helps show where Jochen Maas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Maas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Proteasome inhibitors: a novel class of potent and effective antitumor agents. Hit paper breakdown → | 1999 | 1240 |
| 2 | 2003 | 216 | |
| 3 | 1997 | 97 | |
| 4 | 2013 | 86 | |
| 5 | 2006 | 75 | |
| 6 | 2006 | 53 | |
| 7 | 2006 | 39 | |
| 8 | 1998 | 31 | |
| 9 | 2002 | 27 | |
| 10 | 2000 | 22 | |
| 11 | 2006 | 18 | |
| 12 | 2000 | 14 | |
| 13 | 2002 | 13 | |
| 14 | 2019 | 9 | |
| 15 | Jackknife stability of a tractor semi-trailer combination | 2007 | 5 |
| 16 | 1988 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2024 | 1 | |
| 19 | 2010 | 1 | |
| 20 | 2018 | 1 |
About Jochen Maas
Jochen Maas is a scholar working on Pharmacology, Pharmaceutical Science, Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (2 papers), Radiation Dose and Imaging (2 papers), Chemical Reactions and Isotopes (2 papers), Pharmaceutical studies and practices (2 papers), Diet and metabolism studies (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Hematology (306 citations), Oncology (510 citations), Molecular Biology (1.1k citations), Pharmacology (123 citations) and Hepatology (86 citations). Jochen Maas has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Douglas Lazarus, J I Johnson, Julian Adams, Vito J. Palombella, Christine Pien, Edward A. Sausville, Antonia T. Destree, Peter J. Elliott, Andreas W. Herling and Karl Seeger. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Drug Metabolism Reviews, Biochimica et Biophysica Acta (BBA) - General Subjects, Journal of drug targeting and Handbook of experimental pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.